Clinical Trial Details


Research Study Summary

Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems in the Treatment of Subjects With Atherosclerotic De Novo or Restenotic Lesions in the Native Superficial Femoral Artery and/or Native Proximal Popliteal Artery.


This study is for patients with moderate to severe blockages in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) in the leg. This study is designed to determine the safety and effectiveness of the Absolute Pro Peripheral Self-Expanding Stent System and may reduce critical limb ischemia and major limb amputation. The study involves a 3 year follow-up that includes physical exam, x-ray, ultrasound, and quality of life questionnaires.

To Learn more

CW ID: 180771
Date Last Changed: July 19, 2013

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type


Rebecca Palermo, Manager, Heart and Vascular Research
Rex Healthcare
4420 Lake Boone Trail
Raleigh, NC 27607
Phone: 919-784-3795

View Map

Research Center Information:

Rex Healthcare

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.